| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.3M | — | +4.4% |
| Cost of Revenue | $2.3M | — | +5.7% |
| Gross Profit | $47K | — | -35.6% |
| R&D Expense | $691K | — | +24.5% |
| SG&A Expense | $2.4M | — | +137.9% |
| Operating Income | -$6.4M | — | -257.1% |
| Interest Expense | $226K | — | -35.4% |
| Pre-tax Income | -$6.7M | — | -208.4% |
| Income Tax | $36K | — | — |
| Net Income | -$6.7M | — | -210.0% |
| EPS (Basic) | -$0.41 | — | +43.8% |
| EPS (Diluted) | -$0.41 | — | +43.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.8M | +527.4% | — |
| Accounts Receivable | $1.7M | +7.0% | — |
| Current Assets | $5.8M | +140.3% | — |
| Total Assets | $5.9M | +135.6% | — |
| Current Liabilities | $10.2M | +26.3% | — |
| Long-term Debt | $5.9M | +4.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.4M | — | -211.4% |
| Capital Expenditures | $11K | — | — |
| Investing Cash Flow | -$11K | — | — |
| Financing Cash Flow | $7.6M | — | +257.6% |
| Free Cash Flow | -$4.4M | — | — |
| Total Liabilities | $16.1M | +17.1% | — |
| Stockholders' Equity | -$15.0M | +33.9% | +7.2% |